Pages that link to "Q42725631"
Jump to navigation
Jump to search
The following pages link to Krista L Lanctôt (Q42725631):
Displaying 50 items.
- Major Depressive Disorder Predicts Completion, Adherence, and Outcomes in Cardiac Rehabilitation (Q22305457) (← links)
- Benzodiazepine Use and Driving (Q22305460) (← links)
- Pharmacological interventions for apathy in Alzheimer's disease (Q24185815) (← links)
- Latrepirdine for Alzheimer's disease (Q24186444) (← links)
- Dimebon for Alzheimer's disease (Q24234998) (← links)
- Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits (Q24538295) (← links)
- Depression rating scales for detection of major depression in people with dementia (Q26470556) (← links)
- A meta-analysis of lipid peroxidation markers in major depression (Q26778489) (← links)
- Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future (Q26864905) (← links)
- Cognitive Outcomes following Transcatheter Aortic Valve Implantation: A Systematic Review (Q27001575) (← links)
- Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic (Q28194196) (← links)
- Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease (Q28249186) (← links)
- Interleukin-17 in post-stroke neurodegeneration (Q28284665) (← links)
- A meta-analysis of cytokines in Alzheimer's disease (Q28289922) (← links)
- A positron emission tomography study of 5-hydroxytryptamine-1A receptors in Alzheimer disease (Q28306131) (← links)
- Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia. (Q30575371) (← links)
- Thrombotic thrombocytopenic purpura associated with clopidogrel: further evaluation. (Q33343620) (← links)
- Lipid Peroxidation Markers in Coronary Artery Disease Patients with Possible Vascular Mild Cognitive Impairment (Q33787909) (← links)
- Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating study. (Q33895279) (← links)
- Do atypical antipsychotics cause stroke? (Q33984910) (← links)
- Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease (Q34122935) (← links)
- Pharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm? (Q34146983) (← links)
- Effects of ω-3 fatty acids on cognitive performance: a meta-analysis (Q34150618) (← links)
- Current and emerging drug treatment options for Alzheimer's disease: a systematic review. (Q34222721) (← links)
- Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis (Q34269777) (← links)
- Kynurenine and depressive symptoms in a poststroke population (Q34274565) (← links)
- Atypical antipsychotics and risk of cerebrovascular accidents. (Q34323635) (← links)
- Potential roles of zinc in the pathophysiology and treatment of major depressive disorder (Q34337912) (← links)
- Zinc in depression: a meta-analysis. (Q34353975) (← links)
- Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial (Q34370011) (← links)
- Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial (Q34380997) (← links)
- Therapy for Alzheimer's Disease: How Effective are Current Treatments? (Q34409349) (← links)
- The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-Derived Neurotrophic Factor (BDNF): A Meta-Analysis (Q34540937) (← links)
- The effect of acute exercise on blood concentrations of brain-derived neurotrophic factor in healthy adults: a meta-analysis (Q34556534) (← links)
- Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis (Q34628055) (← links)
- Treatment effects in multiple cognitive domains in Alzheimer's disease: a two-year cohort study (Q34629649) (← links)
- Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis (Q34648742) (← links)
- The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment. (Q34662653) (← links)
- A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice (Q34884984) (← links)
- Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition (Q34992886) (← links)
- Ceramides predict verbal memory performance in coronary artery disease patients undertaking exercise: a prospective cohort pilot study (Q35065194) (← links)
- Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease. (Q35066849) (← links)
- Cardiopulmonary fitness correlates with regional cerebral grey matter perfusion and density in men with coronary artery disease (Q35118942) (← links)
- Genetic predictors of response to treatment with citalopram in depression secondary to traumatic brain injury. (Q35124115) (← links)
- Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID). (Q35693632) (← links)
- Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention (Q35735115) (← links)
- Is Cardiac Rehabilitation Exercise Feasible for People with Mild Cognitive Impairment? (Q35805793) (← links)
- Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trials (Q35863316) (← links)
- The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease. (Q35873720) (← links)
- GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia (Q35884948) (← links)